#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14682	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1876	752.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1611	1611	T	851	T,C	569,194	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14682	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1876	752.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1345	1345	C	920	C	821	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14682	16S	1529	1529	99.93	16S.l15.c17.ctg.1	1876	752.8	0	HET	.	.	.	C1525T	.	1525	1525	C	1686	1686	C	658	C,T	462,128	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26480	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3531	730.6	0	.	n	.	0	T695C	SNP	695	695	T	1041	1041	C	1053	C,A,T	954,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26480	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3531	730.6	0	.	n	.	0	A1638G	SNP	1638	1638	A	1984	1984	G	709	G	646	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26480	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3531	730.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2317	2317	C	768	C	694	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26480	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3531	730.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2391	2391	A	800	A	721	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26480	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3531	730.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2943	2943	C	814	C	725	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1006	folP	855	855	100.0	folP.l15.c4.ctg.1	1637	59.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1028	1030	AGC	111;113;118	A;G;C	102;104;105	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2504	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3463	69.6	1	SNP	p	S91F	1	.	.	271	273	TTC	595	597	TTC	71;71;71	T;T;C,T	68;69;68,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2504	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3463	69.6	1	SNP	p	G95N	0	.	.	283	285	GGC	607	609	GGC	79;80;79	G;G;C	76;76;76	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	2504	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3463	69.6	1	SNP	p	D95G	1	.	.	283	285	GGC	607	609	GGC	79;80;79	G;G;C	76;76;76	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	754	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1365	53.4	1	SNP	p	G45D	0	.	.	133	135	GGC	523	525	GGC	100;100;99	G;G;C	94;95;94	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	532	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	940	53.7	0	.	n	.	0	A197.	DEL	197	197	A	465	465	A	120	A	105	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2300	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2949	75.0	1	SNP	p	D86N	0	.	.	256	258	GAC	466	468	GAC	97;97;101	G;A;C	91;89;95	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2300	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2949	75.0	1	SNP	p	R87I	0	.	.	259	261	CGT	469	471	CGT	99;99;98	C;G;T	95;95;94	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2300	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2949	75.0	1	SNP	p	S87R	1	.	.	259	261	CGT	469	471	CGT	99;99;98	C;G;T	95;95;94	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2300	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2949	75.0	1	SNP	p	R87W	0	.	.	259	261	CGT	469	471	CGT	99;99;98	C;G;T	95;95;94	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	2300	parC	2304	2304	100.0	parC.l15.c30.ctg.1	2949	75.0	1	SNP	p	S88P	0	.	.	262	264	TCC	472	474	TCC	98;99;97	T;C;C	92;95;93	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2018	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2871	67.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1672	1674	GGC	69;69;69	G;G;C	67;65;65	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.10.001	penA.10.001	1	1	27	2636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2453	104.1	1	SNP	p	A311V	0	.	.	931	933	GCC	1247	1249	GCC	163;164;165	G;C;C	141;142;145	penA.10.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	2636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2453	104.1	1	SNP	p	I312M	1	.	.	934	936	ATG	1250	1252	ATG	163;159;162	A;T;G	144;141;142	penA.10.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	2636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2453	104.1	1	SNP	p	T316P	0	.	.	946	948	ACC	1262	1264	ACC	173;173;172	A;C;C	149;153;153	penA.10.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	2636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2453	104.1	1	SNP	p	V316T	1	.	.	946	948	ACC	1262	1264	ACC	173;173;172	A;C;C	149;153;153	penA.10.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	2636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2453	104.1	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1763	1765	ACC	103;103;103	A;C;C	99;97;100	penA.10.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	2636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2453	104.1	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1817	1819	GCG	94;94;97	G;C;G	87;86;90	penA.10.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	2636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2453	104.1	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1817	1819	GCG	94;94;97	G;C;G	87;86;90	penA.10.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	2636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2453	104.1	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1940	1942	GGT	86;88;86	G;G;T	85;86;85	penA.10.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	2636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2453	104.1	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1949	1951	AGC	92;93;93	A,G;G;C	88,1;88;90	penA.10.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.10.001	penA.10.001	1	1	27	2636	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2453	104.1	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1967	1969	CCG	103;110;113	C;C;G	98;103;103	penA.10.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4198	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	2842	141.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1472	1474	CCG	63;63;64	C;C;G	59;60;59	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1164	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1880	59.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	445	445	C	54	C	45	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	152	porB1a	984	98	96.94	porB1a.l6.c17.ctg.1	271	13.6	0	.	p	.	0	A251V	NONSYN	751	753	GCG	71	73	CGG	28;29;29	C;G;G	22;21;22	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	152	porB1a	984	246	90.24	porB1a.l6.c17.ctg.2	246	15.1	0	.	p	.	0	A251V	NONSYN	751	753	GCG	25	27	GTA	13;13;13	G;T;A	3;3;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	152	porB1a	984	246	90.24	porB1a.l6.c17.ctg.2	246	15.1	0	.	p	.	0	S271T	NONSYN	811	813	TCG	85	87	ACT	26;26;25	A;C;T	23;23;23	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	152	porB1a	984	246	90.24	porB1a.l6.c17.ctg.2	246	15.1	0	.	p	.	0	Y273D	NONSYN	817	819	TAT	91	93	GAT	25;24;24	G;A;T	23;23;23	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	152	porB1a	984	246	90.24	porB1a.l6.c17.ctg.2	246	15.1	0	.	p	.	0	D274S	NONSYN	820	822	GAT	94	96	AGT	24;25;25	A;G;T	23;24;24	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	152	porB1a	984	246	90.24	porB1a.l6.c17.ctg.2	246	15.1	0	.	p	.	0	N277H	NONSYN	829	831	AAC	103	105	CAC	25;25;25	C;A;C	24;23;24	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	152	porB1a	984	246	90.24	porB1a.l6.c17.ctg.2	246	15.1	0	.	p	.	0	R307E	NONSYN	919	921	AGA	193	195	GAA	4;4;3	G;A;A	4;4;3	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	152	porB1a	984	246	90.24	porB1a.l6.c17.ctg.2	246	15.1	0	.	p	.	0	T311A	NONSYN	931	933	ACA	205	207	GCA	5;5;5	G;C;A	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	152	porB1a	984	246	90.24	porB1a.l6.c17.ctg.2	246	15.1	0	.	p	.	0	E312D	NONSYN	934	936	GAA	208	210	GAC	5;5;5	G;A;C	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	152	porB1a	984	246	90.24	porB1a.l6.c17.ctg.2	246	15.1	0	.	p	.	0	F314I	NONSYN	940	942	TTC	214	216	ATC	6;6;6	A;T;C	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	152	porB1a	984	246	90.24	porB1a.l6.c17.ctg.2	246	15.1	0	.	p	.	0	A316S	NONSYN	946	948	GCG	220	222	TCG	6;6;6	T;C;G	6;6;6	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	152	porB1a	984	246	90.24	porB1a.l6.c17.ctg.2	246	15.1	0	.	p	.	0	V318A	NONSYN	952	954	GTC	226	228	GCC	5;5;5	G;C;C	5;4;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	152	porB1a	984	246	90.24	porB1a.l6.c17.ctg.2	246	15.1	0	.	p	.	0	G319S	NONSYN	955	957	GGC	229	231	AGC	5;5;5	A;G;C	5;5;5	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	152	porB1a	984	246	90.24	porB1a.l6.c17.ctg.2	246	15.1	0	.	p	.	0	G320A	NONSYN	958	960	GGT	232	234	GCC	5;5;5	G;C;C	5;5;4	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	772	152	porB1a	984	246	90.24	porB1a.l6.c17.ctg.2	246	15.1	0	.	p	.	0	G322V	NONSYN	964	966	GGT	238	240	GTT	5;5;5	G;T;T	5;5;5	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	1774	porB1b	1041	1041	98.28	porB1b.l15.c30.ctg.1	1331	126.9	0	.	p	.	0	A196V	NONSYN	586	588	GCC	732	734	GTC	186;184;183	G;T;C	163;157;159	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	1774	porB1b	1041	1041	98.28	porB1b.l15.c30.ctg.1	1331	126.9	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	903	905	CAA	148;147;150	C;A;A	143;142;143	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	1774	porB1b	1041	1041	98.28	porB1b.l15.c30.ctg.1	1331	126.9	0	.	p	.	0	.	INDELS	760	761	AC	907	910	ATCA	159;161;162;161	A;T;C;A	151;153;155;154	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	1774	porB1b	1041	1041	98.28	porB1b.l15.c30.ctg.1	1331	126.9	0	.	p	.	0	.	MULTIPLE	764	765	AC	915	917	GTG	154;145;145	G;T;G	146;134;135	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	1774	porB1b	1041	1041	98.28	porB1b.l15.c30.ctg.1	1331	126.9	0	.	p	.	0	A257D	NONSYN	769	771	GCT	921	923	GAT	159;161;161	G;A;T	144;146;145	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	1774	porB1b	1041	1041	98.28	porB1b.l15.c30.ctg.1	1331	126.9	0	.	p	.	0	A270V	NONSYN	808	810	GCG	960	962	GTA	194;192;195	G;T;A	158;156;160	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	1774	porB1b	1041	1041	98.28	porB1b.l15.c30.ctg.1	1331	126.9	0	.	p	.	0	L277V	NONSYN	829	831	TTA	981	983	GTA	176;177;184	G;T;A	150;152;156	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	1774	porB1b	1041	1041	98.28	porB1b.l15.c30.ctg.1	1331	126.9	0	.	p	.	0	S290T	NONSYN	868	870	TCT	1020	1022	ACT	159;165;164	A;C;T	146;152;152	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	1774	porB1b	1041	1041	98.28	porB1b.l15.c30.ctg.1	1331	126.9	0	.	p	.	0	H292D	NONSYN	874	876	CAT	1026	1028	GAT	167;163;163	G;A;T	157;154;153	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	1774	porB1b	1041	1041	98.28	porB1b.l15.c30.ctg.1	1331	126.9	0	.	p	.	0	Y296H	NONSYN	886	888	TAC	1038	1040	CAC	145;139;147	C;A;C,T	138;132;139,1	.	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	1774	porB1b	1041	1041	98.28	porB1b.l15.c30.ctg.1	1331	126.9	1	SNP	p	G120K	1	.	.	358	360	AAG	504	506	AAG	146;145;146	A;A;G	132;131;130	porB1b.WHO_X_02194c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	1774	porB1b	1041	1041	98.28	porB1b.l15.c30.ctg.1	1331	126.9	1	SNP	p	A121D	1	.	.	361	363	GAC	507	509	GAC	146;135;139	G;A;C	131;120;123	porB1b.WHO_X_02194c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_X_02194c	porB1b.WHO_X_02194c	1	1	539	1774	porB1b	1041	1041	98.28	porB1b.l15.c30.ctg.1	1331	126.9	1	SNP	p	D121N	0	.	.	361	363	GAC	507	509	GAC	146;135;139	G;A;C	131;120;123	porB1b.WHO_X_02194c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	6246	rpoB	4179	4179	99.98	rpoB.l15.c17.ctg.1	4615	131.6	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1849	1851	CAT	143;143;144	C;A;T	126;127;127	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	596	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	1265	45.9	1	SNP	p	V57M	1	.	.	169	171	ATG	663	665	ATG	96;96;98	A;T;G	89;88;90	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
